ArticleEMBO reports2021
Ubiquitination by a Mycobacterium protein that mimics E1 and E3 activities.
Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ubiquitination by a Mycobacterium protein that mimics E1 and E3 activities.EMBO reports · 2021Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycobacterium tuberculosis (Mtb) has evolved various strategies to co-opt the host ubiquitin network to facilitate its proliferation. In the current issue of EMBO Reports, Liu and colleagues (Wang et al, 2021) demonstrate that the Mtb kinase PknG catalyzes ubiquitination by an unprecedented mechanism wherein the reaction starts by ATP hydrolysis occurring at the α-phosphate position, leading to covalent attachment of the modifier to Lys82 of the E2 conjugation enzyme UbcH7. Ubiquitin is then delivered to host proteins important for immunity by a putative peptidase activity also embedded in PknG. This novel activity of PknG expands our understanding of protein ubiquitination mechanisms, which may be harnessed to identify potential therapeutics for fighting Mtb infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.